Enanta Pharmaceuticals Inc
ENTA
Market Cap$112.42M
Close$
$-7.91
250% downside
Current Fair Value
250% downsideOvervalued by 250% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $112.42 Million |
|---|---|
| Enterprise Value | $85.53 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-5.48 |
| Beta | 0.82 |
| Outstanding Shares | 21,238,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.07 |
|---|---|
| PEG | -41.87 |
| Price to Sales | 1.76 |
| Price to Book Ratio | 1.05 |
| Enterprise Value to Revenue | 1.26 |
| Enterprise Value to EBIT | -0.75 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.67 |
| Debt to Equity | 0.51 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Enanta Pharmaceuticals Inc
CEO: Jay Luly